Results 41 to 50 of about 583,930 (192)
Background Despite the remarkable breakthroughs achieved in the management of metastatic melanoma using immunotherapy and targeted therapies, long‐term clinical efficacy is often compromised due to dose‐limiting toxicity and innate or acquired resistance.
Guangtong Deng+9 more
doaj +1 more source
Background: A role for cutaneous human β-papillomavirus (HPV) types as co-factors in the development of non-melanoma skin cancer has been postulated. Here we have investigated the effects of E7 expression on keratinocyte differentiation, proliferation ...
K. Westphal+3 more
doaj +1 more source
The Modified UQ Flap: An Alternative for Other Flaps
Mohammadreza Hassani, MD, MMed (Skin Cancer)+1 more
doaj +1 more source
Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
Despite enormous international efforts, skin melanoma is still a major clinical challenge. Melanoma takes a top place among the most common cancer types and it has one of the most rapidly increasing incidences in many countries around the world.
Hildur Helgadottir+5 more
doaj +1 more source
Nonmelanoma skin cancer (NMSC) represents the most common form of cancer in Caucasians, with continuing increase in incidence worldwide. Basal cell carcinoma (BCC) accounts for 75% of cases of NMSC, and squamous cell carcinoma (SCC) accounts for the remaining majority of NMSC cases.
Vishal Madan, Venura Samarasinghe
openaire +3 more sources
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
Inhibitors of the BET family proteins are limited by their potency and oral bio-availability. Here, the authors report a new BET inhibitor, NHWD-870, with improved potency compared to previous BET inhibitors, and show that it suppresses BRD4 and targets ...
Mingzhu Yin+14 more
doaj +1 more source
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
The immune system has many sophisticated mechanisms to balance an extensive immune response. Distinct immunosuppressive cells could protect from excessive tissue damage and autoimmune disorders.
Viktor Fleming+15 more
doaj +1 more source
Untargeted metabolomics yields insight into extramammary Paget’s disease mechanisms
BackgroundExtramammary Paget’s disease (EMPD) is a rare cutaneous malignancy, commonly affecting the external genitalia and perianal area of the elderly with unclear pathogenesis.
Long Jiang+18 more
doaj +1 more source
The dermatoscopic universe of basal cell carcinoma
Following the first descriptions of the dermatoscopic pattern of basal cell carcinoma (BCC) that go back to the very early years of dermatoscopy, the list of dermatoscopic criteria associated with BCC has been several times updated and renewed.
Aimilios Lallas+7 more
doaj +1 more source
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
Background Immunotherapies for malignant melanoma are challenged by the resistance developed in a significant proportion of patients. Myeloid-derived suppressor cells (MDSC), with their ability to inhibit antitumor T-cell responses, are a major ...
Adelheid Cerwenka+10 more
doaj +1 more source